# Ribavirin

NDC: 68682-019
Generic name: Ribavirin
Labeler / Manufacturer: Oceanside Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SOLUTION
Routes: RESPIRATORY (INHALATION)
Marketing started: 20170414

FDA application: NDA018859

## Active ingredients

- RIBAVIRIN: 6 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68682-019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68682-019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d74aa4f3-0b7d-480d-b5bf-41ddf808b260
